TrialJournal of clinical hypertension (Greenwich, Conn.)2017

Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.

Joel M Neutel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.